Home / Encoxel 40 MG Injection
Encoxel 40 MG Injection

Encoxel 40 MG Injection

(0 customer reviews)

$26.00 / unit

Available Options

Pack SizePricePrice / UnitQuantityAction
10 Injections$194.00$19.40/unit
8 Injections$155.00$19.38/unit
6 Injections$117.00$19.50/unit
4 Injections$82.00$20.50/unit
2 Injection$46.00$23.00/unit
1 Injection$26.00$26.00/unit
Looking for bulk / B2B pricing?

Product Description

ENCOXEL 40 MG INJECTION

What is this medicine?

ENCOXEL 40 MG INJECTION contains Enoxaparin Sodium 40 mg/0.4 mL (equivalent to 4,000 IU anti-factor Xa activity) and is manufactured and marketed by Celon Laboratories Pvt. Ltd. It is available as a sterile injectable solution, commonly supplied in a 0.4 mL prefilled syringe (PFS). Some suppliers list packs containing two prefilled syringes.

Enoxaparin belongs to a group of medicines called low-molecular-weight heparins (LMWHs), also known as anticoagulants. It is used to prevent and treat harmful blood clots in the blood vessels.

This medicine works by enhancing the activity of antithrombin, a naturally occurring substance that helps regulate blood clotting. It mainly inhibits activated clotting factor Xa and, to a lesser extent, thrombin (factor IIa).

By reducing clot formation, enoxaparin helps prevent new blood clots and stops existing clots from becoming larger while the body gradually breaks them down.

This medicine is commonly used for:

  • prevention of deep vein thrombosis (DVT)

  • prevention of blood clots after certain surgical procedures

  • prevention of venous thromboembolism in hospitalized patients with reduced mobility

  • prevention of blood clots following hip or knee replacement surgery

  • prevention of pulmonary embolism (PE) in patients at risk

  • treatment of DVT and pulmonary embolism using an appropriate weight-based regimen

  • management of unstable angina

  • treatment of certain types of heart attack, including non-ST-elevation myocardial infarction (NSTEMI)

  • treatment of ST-elevation myocardial infarction (STEMI) as part of a prescribed medical protocol

Encoxel 40 mg is a commonly used preventive-strength enoxaparin injection. The 40 mg dose is frequently prescribed once daily for clot prevention in eligible adults.

However, treatment of an existing blood clot generally requires weight-based dosing, which may differ substantially from 40 mg.

Encoxel 40 mg is a prescription anticoagulant medicine and should be used only under appropriate medical supervision.

What should I tell my health care provider before I take this medicine?

They need to know if you have any of these conditions:

  • active bleeding

  • a history of serious bleeding

  • bleeding disorders

  • low platelet counts

  • thrombocytopenia

  • heparin-induced thrombocytopenia (HIT)

  • a history of HIT associated with blood clots

  • stomach ulcers

  • gastrointestinal bleeding

  • recent brain hemorrhage

  • previous hemorrhagic stroke

  • uncontrolled high blood pressure

  • kidney disease

  • severe kidney impairment

  • if you are receiving dialysis

  • liver disease

  • heart disease

  • artificial or mechanical heart valves

  • recent major surgery

  • recent brain or spinal surgery

  • spinal cord disorders

  • a history of spinal injuries

  • if you have an epidural catheter

  • if you are undergoing spinal or epidural anesthesia

  • if you are scheduled for a lumbar puncture

  • diabetic retinopathy

  • blood vessel abnormalities

  • recent serious injury or trauma

  • a history of frequent bruising

  • unexplained bleeding

  • if you are taking blood-thinning medicines

  • if you are taking aspirin

  • if you are taking anti-inflammatory pain medicines

  • if you are taking antiplatelet medicines

  • if you are pregnant or planning to become pregnant

  • if you are breastfeeding

  • an unusual or allergic reaction to enoxaparin

  • an allergy to heparin

  • an allergy to pork-derived products

  • an allergy to any ingredient in the injection

Do not use Encoxel 40 mg if you have active major bleeding or a known serious allergy to enoxaparin, heparin, or relevant pork-derived products.

Enoxaparin is also contraindicated in patients who have experienced immune-mediated heparin-induced thrombocytopenia within the previous 100 days or who have circulating HIT antibodies.

Important spinal bleeding warning: Patients receiving enoxaparin who undergo spinal or epidural anesthesia or spinal puncture may develop spinal or epidural hematomas. These can cause long-term or permanent paralysis.

Tell your healthcare professional if you have any history of spinal procedures, recent surgery, or bleeding complications before receiving Encoxel.

How should I use this medicine?

Encoxel 40 mg Injection should be administered exactly as directed by your doctor or healthcare professional.

It is generally given as a subcutaneous injection (under the skin), usually into the abdominal area.

A healthcare professional may administer the injection or train a patient or caregiver to administer it safely at home.

Do not inject Encoxel into a muscle.

Certain enoxaparin regimens for acute coronary syndromes involve intravenous administration by healthcare professionals, but the usual 40 mg prefilled syringe is primarily used for subcutaneous treatment.

General dosing information:

For prevention of deep vein thrombosis in medical patients:

A commonly recommended adult dose is 40 mg subcutaneously once daily for patients with severely restricted mobility during an acute illness, when anticoagulant prevention is appropriate.

For prevention of blood clots after abdominal surgery:

A commonly recommended regimen is 40 mg subcutaneously once daily, with the first dose and duration determined by the surgical protocol.

For prevention of blood clots after hip or knee replacement surgery:

Enoxaparin may be prescribed in different preventive regimens, including 30 mg twice daily or 40 mg once daily in selected circumstances.

The correct regimen depends on the surgical procedure, treatment timing, kidney function, and patient-specific risk factors.

For treatment of DVT or pulmonary embolism:

Treatment doses are generally calculated according to body weight.

Common adult treatment regimens include 1 mg/kg every 12 hours or 1.5 mg/kg once daily in selected circumstances.

A 40 mg syringe should not be assumed to provide adequate treatment for an existing blood clot.

For unstable angina or NSTEMI:

Enoxaparin is generally prescribed according to a weight-based treatment protocol, often alongside appropriate antiplatelet treatment.

For STEMI:

Treatment depends on age, kidney function, weight, and the specific heart attack management protocol.

For patients with severe kidney impairment:

Dose adjustment is required for certain indications when creatinine clearance is below 30 mL/min.

For example, a common preventive regimen may be reduced to 30 mg once daily in severe renal impairment.

For older adults:

Dosage depends on the indication, body weight, kidney function, and bleeding risk.

For children:

Pediatric use requires specialist supervision and appropriate weight-based dosing. The 40 mg prefilled syringe is not suitable for every pediatric patient.

How to administer Encoxel Injection

If a healthcare professional has trained you to self-administer it:

  1. Wash your hands thoroughly.

  2. Check the syringe label, strength, expiration date, and solution.

  3. Select an appropriate injection site on the abdomen, avoiding the area close to the navel, bruises, scars, or irritated skin.

  4. Clean the injection area according to your healthcare professional's instructions.

  5. Carefully remove the needle cap without touching the needle.

  6. Do not expel the air bubble from a standard prefilled syringe unless the specific product instructions or your healthcare professional direct otherwise.

  7. Gently pinch a fold of skin.

  8. Insert the needle as demonstrated by your healthcare professional, usually at a 90-degree angle for a suitable skin fold.

  9. Inject the prescribed dose slowly and steadily.

  10. Withdraw the needle and activate the safety mechanism if present.

  11. Do not rub or massage the injection site.

  12. Dispose of the syringe immediately in an approved sharps container.

Important administration instructions:

  • Use the injection at the prescribed time.

  • Do not change the dose yourself.

  • Do not inject into a muscle.

  • Do not reuse a prefilled syringe.

  • Rotate injection sites as instructed.

  • Avoid rubbing the injection area after administration.

  • Do not stop treatment without medical advice.

  • Attend recommended blood tests and medical reviews.

  • Report unusual bleeding or bruising promptly.

Overdosage: Excessive enoxaparin can cause serious or life-threatening bleeding.

Seek emergency medical attention if you believe too much has been administered.

Possible symptoms include:

  • uncontrolled bleeding

  • severe bruising

  • blood in urine

  • black or bloody stools

  • vomiting blood

  • severe headache

  • dizziness or fainting

  • sudden weakness

  • severe abdominal pain

In medical settings, protamine sulfate may be used to partially reverse enoxaparin's anticoagulant effects. It does not completely neutralize anti-factor Xa activity.

NOTE: This medicine is only for you. Do not share it with others.

What if I miss a dose?

If you miss a scheduled dose of Encoxel 40 mg Injection, contact your healthcare professional for advice.

If you have been trained to self-administer enoxaparin, your doctor may provide instructions on how to handle a missed dose.

Take or administer the missed dose only according to those instructions.

If it is nearly time for your next scheduled injection, do not automatically take an additional dose.

Do not administer two injections together to make up for a missed dose.

The correct action depends on whether Encoxel is being used to prevent blood clots or treat an existing clot.

If you miss a dose during treatment for DVT, pulmonary embolism, or a heart-related condition, contact your healthcare professional promptly.

Do not discontinue anticoagulant treatment without medical advice.

What may interact with this medicine?

Important interactions include:

  • warfarin

  • apixaban

  • rivaroxaban

  • dabigatran

  • edoxaban

  • unfractionated heparin

  • other low-molecular-weight heparins

  • fondaparinux

  • aspirin

  • clopidogrel

  • prasugrel

  • ticagrelor

  • ibuprofen

  • diclofenac

  • naproxen

  • ketorolac

  • other nonsteroidal anti-inflammatory drugs (NSAIDs)

  • alteplase

  • tenecteplase

  • other thrombolytic medicines

  • certain selective serotonin reuptake inhibitors (SSRIs)

  • certain serotonin-norepinephrine reuptake inhibitors (SNRIs)

  • certain herbal supplements that may affect bleeding

Other anticoagulants:

Combining enoxaparin with medicines such as warfarin, apixaban, rivaroxaban, or heparin may increase bleeding risk.

Some combinations are deliberately used for short periods during anticoagulant transitions, but they require careful medical supervision.

Antiplatelet medicines:

Medicines such as aspirin, clopidogrel, prasugrel, and ticagrelor may increase the risk of bleeding when combined with enoxaparin.

These combinations may be necessary in certain cardiovascular conditions but should only be used as prescribed.

NSAID pain relievers:

Medicines such as ibuprofen, diclofenac, naproxen, and ketorolac may increase the risk of gastrointestinal and other bleeding complications.

Do not take these medicines with Encoxel without medical advice.

Thrombolytic medicines:

Medicines used to dissolve blood clots, such as alteplase or tenecteplase, may significantly increase bleeding risk when used with enoxaparin.

Such treatment requires hospital supervision.

Antidepressants:

Certain SSRIs and SNRIs may increase bleeding risk by affecting platelet function.

Herbal supplements:

Some herbal products may affect blood clotting or increase bleeding risk, particularly when combined with anticoagulants.

Tell your healthcare professional about all supplements you use.

Other injectable anticoagulants:

Do not substitute enoxaparin with another low-molecular-weight heparin on a unit-for-unit basis unless a qualified healthcare professional specifically directs the change.

Different anticoagulants are not automatically interchangeable.

This list may not describe all possible interactions.

Give your healthcare provider a complete list of all prescription medicines, non-prescription drugs, herbs, vitamins, and dietary supplements you use.

Also tell your doctor if you drink alcohol or use recreational drugs.

What should I watch for while using this medicine?

Encoxel 40 mg Injection helps prevent and treat harmful blood clots, but careful monitoring is essential because anticoagulants can increase the risk of bleeding.

Bleeding precautions:

Enoxaparin reduces the blood's ability to form clots.

Contact your healthcare professional immediately if you experience:

  • unusual or excessive bruising

  • prolonged bleeding from cuts

  • frequent nosebleeds

  • bleeding gums

  • unusually heavy menstrual bleeding

  • blood in the urine

  • black or bloody stools

  • vomiting blood

Seek emergency medical care for severe or uncontrolled bleeding.

Internal bleeding:

Internal bleeding may occur without obvious external symptoms.

Seek urgent medical attention if you develop severe headache, sudden weakness, fainting, severe abdominal pain, or unexplained shortness of breath.

Spinal or epidural hematoma:

Patients undergoing spinal anesthesia, epidural anesthesia, or lumbar puncture while receiving enoxaparin are at risk of serious bleeding around the spinal cord.

Seek emergency medical attention if you develop:

  • severe back pain

  • numbness or tingling in the legs

  • muscle weakness

  • difficulty walking

  • loss of bladder control

  • loss of bowel control

These symptoms may indicate spinal cord compression and require immediate treatment to prevent permanent paralysis.

Heparin-induced thrombocytopenia:

Enoxaparin may rarely cause heparin-induced thrombocytopenia (HIT), a serious immune reaction that reduces platelet counts and can paradoxically cause blood clots.

Your healthcare professional may monitor platelet counts during treatment.

Contact your doctor if you develop unusual bruising, new leg swelling, chest pain, or signs of clot formation.

Kidney function:

Enoxaparin is partly eliminated through the kidneys.

Patients with reduced kidney function may have higher drug exposure and an increased bleeding risk.

Kidney function should be assessed before treatment and monitored when appropriate.

Blood tests:

Your healthcare professional may recommend:

  • complete blood count (CBC)

  • platelet count

  • hemoglobin

  • hematocrit

  • kidney function tests

  • anti-factor Xa testing in selected patients

Routine INR testing is not used to measure the anticoagulant effect of enoxaparin.

Injection-site reactions:

Mild bruising, redness, or discomfort may occur after subcutaneous administration.

Avoid rubbing the injection site.

Report severe swelling, persistent pain, skin discoloration, or skin damage.

Surgery and dental procedures:

Tell your surgeon, dentist, or anesthetist that you are receiving enoxaparin before any procedure.

Your doctor will decide whether treatment needs to be temporarily interrupted.

Pregnancy:

Enoxaparin may be prescribed during pregnancy when anticoagulation is medically necessary.

It does not significantly cross the placenta, but treatment requires specialist monitoring.

Pregnant patients with mechanical prosthetic heart valves require particular caution because serious clotting complications have been reported despite anticoagulant treatment.

Breastfeeding:

Enoxaparin is generally considered compatible with breastfeeding because meaningful absorption by the infant is unlikely. Discuss your individual circumstances with your healthcare professional.

Prevention of injuries:

Avoid activities that could cause significant injuries or bleeding.

Use a soft toothbrush and take care when shaving.

Do not stop Encoxel without medical advice. Prematurely stopping anticoagulant treatment may increase the risk of dangerous blood clots.

What side effects may I notice from this medicine?

Side effects that you should report to your doctor or healthcare professional as soon as possible:

  • severe or uncontrolled bleeding

  • coughing or vomiting blood

  • black or bloody stools

  • blood in the urine

  • severe or persistent nosebleeds

  • unusual or extensive bruising

  • severe headache

  • sudden confusion or weakness

  • severe dizziness or fainting

  • difficulty breathing

  • chest pain

  • severe abdominal pain

  • new or worsening leg swelling

  • symptoms of heparin-induced thrombocytopenia

  • severe back pain after spinal or epidural procedures

  • numbness or weakness in the legs

  • loss of bladder or bowel control

  • severe allergic reaction

  • swelling of the face, lips, tongue, or throat

  • difficulty swallowing

  • severe skin rash

  • skin necrosis or significant discoloration around the injection site

  • severe reduction in platelet counts

Side effects that usually do not require immediate medical attention (report them if they continue or are bothersome):

  • mild injection-site pain

  • mild redness at the injection site

  • small bruises around the injection area

  • minor swelling at the injection site

  • mild irritation

  • headache

  • nausea

  • mild changes in liver enzyme levels

The commonly reported adverse effects of enoxaparin include bleeding, anemia, thrombocytopenia, and injection-site reactions.

Some patients may also experience increases in liver enzymes during treatment.

Rare but serious adverse reactions include major hemorrhage, HIT, spinal or epidural hematomas, and severe allergic reactions.

The risk of adverse effects depends on kidney function, body weight, medical conditions, dosage, and the use of other medicines that affect blood clotting.

This list may not describe all possible side effects.

Contact your healthcare professional if any side effect becomes persistent, severe, or unusual.

Where should I keep my medicine?

Keep out of the reach of children and pets.

Store Encoxel 40 mg Injection according to the instructions printed on the original packaging. Product-specific suppliers list storage at 15°C to 25°C or below 25°C, while another Indian pharmacy listing advises refrigeration. Because these instructions differ, confirm the requirements for the exact supplied pack with the manufacturer or pharmacist. Do not freeze.

Keep the prefilled syringe in its original protective packaging until ready for use.

Protect the injection from:

  • excessive heat

  • direct sunlight

  • freezing temperatures

  • moisture

  • contamination

  • physical damage

  • accidental exposure to children

Do not use the injection if the syringe is cracked, leaking, or damaged.

Inspect the solution before use. It should normally be clear and colorless to pale yellow.

Do not use the injection if it contains visible particles or shows unusual discoloration.

Each prefilled syringe is intended for single use only.

Do not reuse needles or syringes.

Dispose of used syringes immediately in an approved puncture-resistant sharps container.

Do not place exposed needles in ordinary household waste.

Do not use Encoxel 40 mg Injection after the expiration date printed on the packaging.

Expired or unused injections should be disposed of according to local pharmacy or healthcare-waste disposal recommendations.

Last Updated on 01/11/2026

Medically Written ByDr. Marcus Vance, PharmDDr. Marcus Vance, PharmD

Last Updated on 01/11/2026

Medically Reviewed ByDr. Rachel Peter, PharmD, PhDDr. Rachel Peter, PharmD, PhD